LSE:ULVR
LSE:ULVRPersonal Products

Unilever (LSE:ULVR) Valuation Check After Recent Share Price Pullback

Unilever (LSE:ULVR) has been quietly treading water, with the share price slipping about 4% over the past month yet still delivering solid gains over the past 3 years, which raises an interesting valuation question. See our latest analysis for Unilever. Over the past year, Unilever’s modest 1 year total shareholder return of 2.31%, alongside a slightly negative 90 day share price return, suggests momentum has cooled a bit even as management pushes through gradual, margin focused changes. If...
LSE:AZN
LSE:AZNPharmaceuticals

Taking Stock of AstraZeneca (LSE:AZN): Is Its 31% One-Year Return Now Fully Valued?

AstraZeneca (LSE:AZN) has quietly ground out solid gains over the past year, and today’s move is less about a flashy headline and more about how that trend stacks up against its fundamentals. See our latest analysis for AstraZeneca. The latest dip in AstraZeneca’s £135.92 share price comes after a strong run, with a 90 day share price return of 7.45% contributing to a 1 year total shareholder return of 31.08%, suggesting momentum is still broadly constructive. If AstraZeneca’s steady progress...